Effect of dietary fat content on oral bioavailability of menatetrenone in humans

Journal of Pharmaceutical Sciences

Volumn 85, Issue 9, 1996, Pages 1012-1016

  Uematsu, Toshihiko ^a   Nagashima, Satoru ^b   Niwa, Masayuki ^a   Kohno, Ken Ichi ^a   Sassa, Toshi ^a   Ishii, Mika ^c   Tomono, Yoshiro ^c   Yamato, Chiyuki ^c   Kanamaru, Mitsutaka ^d  

^a GIFU UNIVERSITY   (Japan)

^b GEORGETOWN UNIVERSITY   (United States)

^c EISAI CO LTD   (Japan)

^d Shitoro Clinic   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MENATETRENONE;

ADULT; ARTICLE; BLOOD CLOTTING; BONE ATROPHY; BONE DENSITY; CALORIE; CLINICAL ARTICLE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EFFECT; FAT INTAKE; FRACTURE HEALING; HUMAN; MALE; MINERALIZATION; ORAL DRUG ADMINISTRATION;

EID: 9544238077     PISSN: 00223549     EISSN: None     Source Type: Journal    
DOI: 10.1021/js9600641     Document Type: Article

References (19)

1. Bouchaert, J. H.; Said, A. H. Nature 1960, 185, 849.
2. Price, P. A. Vitam. Horm. 1986, 42, 65-108.
3. Hauschka, P. V.; Lian, J. B.; Gallop, P. M. Proc. Natl. Acad. Sci. U.S.A. 1976, 73, 1447-1451.
4. Akiyama, Y.; Hara, K.; Ohkawa, I.; Tajima, T. Jpn. J. Pharmacol. 1993, 62, 145-153.
5. Koshihara, Y.; Hoshi, K.; Shiraki, M. J. Clin. Exp. Med. 1992, 161, 439-440.
6. Orimo, H.; Shiraki, M.; Fujita, T., Onomura, T.; Inoue, T.; Kushida, K. J. Bone Miner. Res. 1992, 7 (Suppl. 1), S122.
7. Ishii, M.; Shimomura, M.; Hasegawa, J.; Tomono, Y.; Yamato, C.; Yamano, Y.; Inai, Y.; Okano, K.; Ohno, T.; Yamazaki, K.; Kayano, M.; Kanamaru, M.; Nakashima, M. Jpn. Pharmacol. Ther. 1995, 23, 2677-2682 (in Japanese).
8. Reports from the Ministry of Health and Wealth, Japan: Nutritional requirement for Japanese people (Ver. IV). Dai-ichi Shuppan, Tokyo, pp 10-41, 1990.
9. Reports from the Ministry of Health and Wealth, Japan: Nutritional state of Japanese people in 1993. Dai-ichi Shuppan, Tokyo, pp 29-64, 1993.
10. Nakagawa, T.; Takechi, M.; Ohkawa, T.; Inoue T.; Mano, M. Proc. Annu. Meet. Jpn. Soc. Pharm. Sci. 1995, 4, 176.
11. Colburn, W. A.; Gibson, D. M.; Rodriguez, L. C.; Bugge, C. J. L.; Blumenthal, H. P. J. Clin. Pharmacol. 1985, 25, 583-589.
12. De Marco, T.; Levine, R. J. Pharmacol. Exp. Ther. 1969, 169, 142-151.
13. Muranushi, N.; Kinugawa, M.; Nakajima, Y.; Muranishi, S.; Sezaki, H. Int. J. Pharmac. 1980, 4, 271-279.
14. Bates, T. R.; Seqieora, J. J. Pharm. Sci. 1980, 64, 793-797.
15. Palin, K. J.; Wilson, C. G.; Davis, S. S.; Phillips, A. J. J. Pharm. Pharmacol. 1982, 34, 707-710.
16. Tucker, G. Lancet 1993, 341, 1314-1315.
17. Tadano, K.; Yuzuriha, T.; Ikeuchi, T.; Sato, T.; Fujita, T. J. Pharmacobio-Dyn. 1989, 12, 646-651.
18. Shiraki, M. Shin'yaku to Rinsho 1992, 41, 1249-1279 (in Japanese).
19. Marcus, R.; Coulson, A. M. In Goodman and Oilman's the Pharmacological Basis of Therapeutics; Gilman, A. G., Rail, T. W., Nies, A. S., Taylor, P., Eds.; Pergamon Press: New York, 1990; pp 1564-1565. .